Radiosurgery and Avastin for Recurrent Malignant Gliomas
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the central nervous system (CNS) toxicity in patients
with recurrent malignant gliomas treated with concurrent Avastin and stereotactic
radiosurgery (SRS).